BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23039362)

  • 21. Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells.
    Gobessi S; Laurenti L; Longo PG; Carsetti L; Berno V; Sica S; Leone G; Efremov DG
    Leukemia; 2009 Apr; 23(4):686-97. PubMed ID: 19092849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein tyrosine kinases Syk and ZAP-70 display distinct requirements for Src family kinases in immune response receptor signal transduction.
    Zoller KE; MacNeil IA; Brugge JS
    J Immunol; 1997 Feb; 158(4):1650-9. PubMed ID: 9029101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course.
    Dezorella N; Katz BZ; Shapiro M; Polliack A; Perry C; Herishanu Y
    Haematologica; 2016 Dec; 101(12):1553-1562. PubMed ID: 27443285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells.
    Gobessi S; Laurenti L; Longo PG; Sica S; Leone G; Efremov DG
    Blood; 2007 Mar; 109(5):2032-9. PubMed ID: 17038529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemia.
    Gioia R; Trégoat C; Dumas PY; Lagarde V; Prouzet-Mauléon V; Desplat V; Sirvent A; Praloran V; Lippert E; Villacreces A; Leconet W; Robert B; Vigon I; Roche S; Mahon FX; Pasquet JM
    J Pathol; 2015 Sep; 237(1):14-24. PubMed ID: 25965880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LYN Kinase in the Tumor Microenvironment Is Essential for the Progression of Chronic Lymphocytic Leukemia.
    Nguyen PH; Fedorchenko O; Rosen N; Koch M; Barthel R; Winarski T; Florin A; Wunderlich FT; Reinart N; Hallek M
    Cancer Cell; 2016 Oct; 30(4):610-622. PubMed ID: 27728807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling.
    Dielschneider RF; Xiao W; Yoon JY; Noh E; Banerji V; Li H; Marshall AJ; Johnston JB; Gibson SB
    Cell Death Dis; 2014 Oct; 5(10):e1439. PubMed ID: 25275600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia.
    Buchner M; Fuchs S; Prinz G; Pfeifer D; Bartholomé K; Burger M; Chevalier N; Vallat L; Timmer J; Gribben JG; Jumaa H; Veelken H; Dierks C; Zirlik K
    Cancer Res; 2009 Jul; 69(13):5424-32. PubMed ID: 19549911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia.
    ten Hacken E; Scielzo C; Bertilaccio MT; Scarfò L; Apollonio B; Barbaglio F; Stamatopoulos K; Ponzoni M; Ghia P; Caligaris-Cappio F
    Blood; 2013 Mar; 121(12):2264-73. PubMed ID: 23325840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered recruitment of Lyn, Syk and ZAP-70 into lipid rafts of activated B cells in Systemic Lupus Erythematosus.
    Vásquez A; Baena A; González LA; Restrepo M; Muñoz CH; Vanegas-García A; Ortiz-Reyes B; Abdoel N; Rojas M; García LF; Vásquez G
    Cell Signal; 2019 Jun; 58():9-19. PubMed ID: 30840855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct interaction of Syk and Lyn protein tyrosine kinases in rat basophilic leukemia cells activated via type I Fc epsilon receptors.
    Amoui M; Dráberová L; Tolar P; Dráber P
    Eur J Immunol; 1997 Jan; 27(1):321-8. PubMed ID: 9022035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
    Hüttmann A; Klein-Hitpass L; Thomale J; Deenen R; Carpinteiro A; Nückel H; Ebeling P; Führer A; Edelmann J; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2006 Oct; 20(10):1774-82. PubMed ID: 16932341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sorafenib targets BCR kinases and blocks migratory and microenvironmental survival signals in CLL cells.
    López-Guerra M; Xargay-Torrent S; Pérez-Galán P; Saborit-Villarroya I; Rosich L; Villamor N; Aymerich M; Roué G; Campo E; Montserrat E; Colomer D
    Leukemia; 2012 Jun; 26(6):1429-32. PubMed ID: 22182921
    [No Abstract]   [Full Text] [Related]  

  • 34. Syk-dependent phosphorylation of CLEC-2: a novel mechanism of hem-immunoreceptor tyrosine-based activation motif signaling.
    Séverin S; Pollitt AY; Navarro-Nuñez L; Nash CA; Mourão-Sá D; Eble JA; Senis YA; Watson SP
    J Biol Chem; 2011 Feb; 286(6):4107-16. PubMed ID: 21098033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syk, but not Lyn, recruitment to B cell antigen receptor and activation following stimulation of CD45- B cells.
    Pao LI; Cambier JC
    J Immunol; 1997 Mar; 158(6):2663-9. PubMed ID: 9058799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemia.
    Wagner M; Oelsner M; Moore A; Götte F; Kuhn PH; Haferlach T; Fiegl M; Bogner C; Baxter EJ; Peschel C; Follows GA; Ringshausen I
    Blood; 2016 Jan; 127(4):436-48. PubMed ID: 26508782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia.
    Cui B; Chen L; Zhang S; Mraz M; Fecteau JF; Yu J; Ghia EM; Zhang L; Bao L; Rassenti LZ; Messer K; Calin GA; Croce CM; Kipps TJ
    Blood; 2014 Jul; 124(4):546-54. PubMed ID: 24914134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.
    Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I
    Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies.
    Cesano A; Perbellini O; Evensen E; Chu CC; Cioffi F; Ptacek J; Damle RN; Chignola R; Cordeiro J; Yan XJ; Hawtin RE; Nichele I; Ware JR; Cavallini C; Lovato O; Zanotti R; Rai KR; Chiorazzi N; Pizzolo G; Scupoli MT
    Haematologica; 2013 Apr; 98(4):626-34. PubMed ID: 23144194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monovalent and multivalent ligation of the B cell receptor exhibit differential dependence upon Syk and Src family kinases.
    Mukherjee S; Zhu J; Zikherman J; Parameswaran R; Kadlecek TA; Wang Q; Au-Yeung B; Ploegh H; Kuriyan J; Das J; Weiss A
    Sci Signal; 2013 Jan; 6(256):ra1. PubMed ID: 23281368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.